Tags: Multiple MyelomaCancerTreatmentRegimen ComparisonsPharmacist
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | 1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | NICE nod for Darzalex with lenalidomide and dexamethasone - 12 months ago | |
| 2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 3 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | All-Oral Therapy Promising in Higher-Risk MDS, CMML - 8 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 10 months ago | |
| 4 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
| 5 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 3 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 9 months ago | |
| 6 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 7 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - 5 months ago | |
| 8 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 9 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 10 | Judy George MedPage Today Medical reporter, writer. |